Patents by Inventor Jeffrey D. Johnson

Jeffrey D. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080289706
    Abstract: An apparatus and method for controlling a water characteristic of a body of water by controlling the cyclic release of a water characteristic material into the body of water with or without the system being responsive to a level of the water characteristic in the body of water.
    Type: Application
    Filed: February 9, 2008
    Publication date: November 27, 2008
    Inventors: Joseph A. King, Jeffrey D. Johnson
  • Publication number: 20080248010
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Application
    Filed: March 17, 2008
    Publication date: October 9, 2008
    Applicant: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Patent number: 7419590
    Abstract: A liquid treatment method and system with the liquid treatment system having a container for holding a liquid treatment material therein with the liquid treatment device effectively positionable in various transitional regions in the liquid system to provide for an enhanced dispersant rate in response to increased activity in the body of water.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: September 2, 2008
    Assignee: King Technology
    Inventors: Joseph A. King, Jeffrey D. Johnson
  • Patent number: 7405289
    Abstract: The present invention provides a pancreatic islet transcription factor and methods of treating and diagnosing diabetes.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: July 29, 2008
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, John F. Palma, Anthony C. Schweitzer, John E. Blume
  • Publication number: 20080126264
    Abstract: The optimization of product prices using business segmentation is provided. The business is segmented into a plurality of selected segments, each including a subset of products. Segmenting utilizes fixed dimensions and variable dimensions. Pricing power and pricing risk is computed for each segment. Pricing power is an ability to alter pricing of the products within the segment. Pricing risk is a risk factor associated with an alteration to pricing of the products within the segment. Pricing objectives are generated for each segment by comparing the pricing power to the pricing risk of the segment. Prices are optimized using the pricing objectives. Prices are set based on optimized prices. Price lists and policies may be managed, including negotiating of prices based on optimized prices. Additionally, the entire system may be linked to an enterprise resource system.
    Type: Application
    Filed: November 12, 2007
    Publication date: May 29, 2008
    Inventors: Jens E. Tellefsen, Jeffrey D. Johnson
  • Patent number: 7344844
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: March 18, 2008
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Patent number: 7294698
    Abstract: The invention relates to methods and reagents for diagnosing and treating diabetes.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: November 13, 2007
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D Johnson, John E. Blume, John F. Palma, Yun-Ping Zhou
  • Patent number: 7144985
    Abstract: The invention relates to methods of determining islet cell activity by detecting the level of Archipelin or a fragment thereof and comparing the level to a baseline level or range associated with a known islet cell activity. Such methods are useful in diagnosing and studying the development of diabetes.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: December 5, 2006
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, John E. Blume, John F. Palma, Yun-Ping Zhou
  • Patent number: 7109021
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: September 19, 2006
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Patent number: 7087394
    Abstract: Expression of beta-TRP is enriched in islet cells. Introduction of expression cassettes encoding beta-TRP into diabetic islet cells improved glucose-stimulated insulin production.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: August 8, 2006
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou
  • Patent number: 7053180
    Abstract: The present invention provides polynucleotides encoding potassium channels as well as methods of using the potassium channels to treat and diagnose diabetes and a predisposition for diabetes.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: May 30, 2006
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, John F. Palma, Anthony C. Schweitzer, John E. Blume
  • Patent number: 7014780
    Abstract: A water treatment device, method and system with the water treatment device having a container for holding a water treatment material therein with the water treatment device including a shroud extending in a direction generally normal to a flow of debris laden water with the shroud inhibiting direct flow of debris into a water inlet in the water treatment device by directing water and debris over the shroud and around the water treatment device while a portion of the water can be directed laterally into the water treatment material within the water treatment device to thereby purify the water that flows over the water treatment materials with the water treatment device including multiple spaced and positioned water inlets so that the likelihood of the water inlet being completely obstructed is remote.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: March 21, 2006
    Assignee: King Technology
    Inventors: Joseph A. King, Jeffrey D. Johnson
  • Publication number: 20040259160
    Abstract: Expression of beta-TRP is enriched in islet cells. Introduction of expression cassettes encoding beta-TRP into diabetic islet cells improved glucose-stimulated insulin production.
    Type: Application
    Filed: March 4, 2004
    Publication date: December 23, 2004
    Applicant: METABOLEX, INC.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou
  • Publication number: 20040176905
    Abstract: A mobile device for a vehicle is disclosed, which uses scripts provided from a server. The scripts can include indications that indicate the appropriateness of input data. Additionally, the scripts can include conditional actions that only occur when certain input data values are recorded.
    Type: Application
    Filed: March 6, 2003
    Publication date: September 9, 2004
    Inventors: Douglas Ray Sanqunetti, Jeffrey D. Johnson, Rena Yamamoto, Peter Thayer
  • Publication number: 20040069698
    Abstract: A water treatment device, method and system with the water treatment device having a container for holding a water treatment material therein with the water treatment device including a shroud extending in a direction generally normal to a flow of debris laden water with the shroud inhibiting direct flow of debris into a water inlet in the water treatment device by directing water and debris over the shroud and around the water treatment device while a portion of the water can be directed laterally into the water treatment material within the water treatment device to thereby purify the water that flows over the water treatment materials with the water treatment device including multiple spaced and positioned water inlets so that the likelihood of the water inlet being completely obstructed is remote.
    Type: Application
    Filed: October 9, 2003
    Publication date: April 15, 2004
    Inventors: Joseph A. King, Jeffrey D. Johnson
  • Publication number: 20040072216
    Abstract: The present invention provides polynucleotides encoding potassium channels as well as methods of using the potassium channels to treat and diagnose diabetes and a predisposition for diabetes.
    Type: Application
    Filed: June 10, 2003
    Publication date: April 15, 2004
    Applicant: METABOLEX, INC.
    Inventors: Jeffrey D. Johnson, John F. Palma, Anthony C. Schweitzer, John E. Blume
  • Patent number: 6685827
    Abstract: A water treatment device, method and system with the water treatment device having a container for holding a water treatment material therein with the water treatment device including a shroud extending in a direction generally normal to a flow of debris laden water with the shroud inhibiting direct flow of debris into a water inlet in the water treatment device by directing water and debris over the shroud and around the water treatment device while a portion of the water can be directed laterally into the water treatment material within the water treatment device to thereby purify the water that flows over the water treatment materials with the water treatment device including multiple spaced and positioned water inlets so that the likelihood of the water inlet being completely obstructed is remote.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: February 3, 2004
    Assignee: King Technology, Inc.
    Inventors: Joseph A. King, Jeffrey D. Johnson
  • Publication number: 20040002114
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of human and murine islet cell G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, methods of screening for modulators of islet cell G-protein coupled receptors and methods of treating mammals with modulators of islet cell G-protein coupled receptor activity.
    Type: Application
    Filed: January 6, 2003
    Publication date: January 1, 2004
    Applicant: METABOLEX, INC.
    Inventors: Francine M. Gregoire, Jeffrey D. Johnson, John E. Blume
  • Publication number: 20030202976
    Abstract: The invention relates to methods and reagents for diagnosing and treating diabetes.
    Type: Application
    Filed: December 2, 2002
    Publication date: October 30, 2003
    Applicant: METABOLEX, INC.
    Inventors: Jeffrey D. Johnson, John E. Blume, John F. Palma, Yun-Ping Zhou
  • Patent number: D557344
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: December 11, 2007
    Assignee: Trafficade Service, Inc.
    Inventor: Jeffrey D. Johnson